Monomer-Dimer Hybrid Immunoconjugates (Violation) > Summary
Court Case Number 337-TA-3586
Filing Date Dec 20, 2021
Docket Number 3586
Investigation Type Violation
Unfair Act Patent Infringement
Institution Date -
Markman Hearing Start Date -
Markman Hearing End Date -
Evidentiary Hearing Scheduled Start Date -
Evidentiary Hearing Scheduled End Date -
Evidentiary Hearing Actual Start Date -
Evidentiary Hearing Actual End Date -
Target Date -
Final ID On Violation Due Date -
Final ID On Violation Issue Date -
Non Final (Terminating) ID Issued -
Final Determination of No Violation -
Final Determination of Violation -
Termination Date Feb 18, 2022
Court International Trade Commission
Status Complaint/Request Withdrawn
Complainant
5Complainant Attorneys
5Bioverativ Therapeutics Inc.
Attorney Name: Scott K. Reed
Venable
Sanofi
Attorney Name: Scott K. Reed
Venable
Genzyme Europe B.V.
Attorney Name: Scott K. Reed
Venable
Bioverativ Inc.
Attorney Name: Scott K. Reed
Venable
Bioverativ Pacific LLC
Attorney Name: Scott K. Reed
Venable
Respondent Attorneys
2Spectrum Pharmaceuticals
Attorney Name: Mark J. Abate
Goodwin Procter LLP
Hanmi Pharmaceutical
Attorney Name: Mark J. Abate
Goodwin Procter LLP
Related Patents
Doc No | Title | Issue date |
---|---|---|
07404956 | Immunoglobulin chimeric monomer-dimer hybrids | Jul 29, 2008 |